Floating Point Research
Investment Thesis
Floating Point invests in companies that build "massive businesses that others don't know exist" -- deliberately targeting structurally complex, often-overlooked sectors that get skipped by trend-driven venture capital. The firm's stated philosophy rests on three pillars: embracing complexity rather than avoiding it, building a concentrated portfolio so partners can go deep with each founder, and providing patient capital suited to businesses that take longer to compound. Founded in 2021 by Eddie Segel and John Loser, both of whom were on the founding team at Oscar Health and previously worked at Bridgewater Associates, the firm applies operator-level pattern recognition from building a large, complex healthcare company to other underserved verticals.
Sector Focus
Floating Point's portfolio clusters around six core areas: healthcare (insurance, digital pharmacy, orthopedic surgery, hospital data, cancer diagnostics), insurance and risk (specialty insurance, flood/climate insurance, insurance brokerage), fintech (private credit infrastructure, credit union technology, alternative investment products, embedded financing), logistics and supply chain (trade/border security data, semiconductor supply chains, real-time freight tracking, electric trucking), real assets and infrastructure (workforce platforms for critical infrastructure, parking automation, building digital twins, land remediation), and climate/energy (carbon capture, renewable energy financing/exchange). A smaller number of investments touch media (an investigative newsroom) and civic infrastructure (open-source voting machines).
Stage Focus
The firm invests across the full early-stage spectrum, from pre-seed through Series B, with the bulk of its roughly 44 disclosed portfolio companies concentrated at Seed and Series A. It also occasionally incubates companies directly (e.g., Sun Day, a tech-enabled carwash roll-up) and made a founding-team-level investment in Oscar Health prior to institutionalizing as a fund.
Check Size
Check size is not disclosed on the firm's website or in available secondary sources. Given a combined AUM of roughly $150M across two funds and a portfolio of more than 40 companies, checks are likely in the low-to-mid six figures at pre-seed/seed, scaling into the high six or low seven figures for Series A/B follow-ons, but this is inferred rather than confirmed.
Lead Tendency
Evidence is mixed and limited. In the most recently identified deal (Coral's $7.5M seed round, March 2026), Floating Point was one of several participating investors, with ResilienceVC leading. No confirmed instance of Floating Point leading a round was found in available sources, so lead tendency is recorded as unknown pending further research.
Recent Activity
Floating Point closed its second fund, Fund II, in April 2024 at $70M -- short of an original $100M target -- bringing total assets under management to over $150M across two vehicles. As of March 2026, third-party trackers report the firm has made roughly 43 investments overall, including 4 in the trailing 12 months, indicating it remains an active investor. The most recent identified deal is a March 2026 participation in Coral, a climate fintech startup that helps HVAC installers apply utility and government rebates at the point of sale, alongside ResilienceVC, Twelve Below, Accion Ventures, Blackhorn Ventures, Remarkable Ventures, New Climate Ventures, and Watsco Ventures.
Portfolio Highlights
The portfolio spans healthcare (Oscar, Ataraxis, Firefly, Pearl Health, Dandelion), insurance (Floodbase, Ledgebrook, QuoteWell), fintech (Setpoint, Bonside, Unlimited), logistics (Altana, Tive, Nevoya), real assets (Odin, Vend, Remedy Scientific), and climate (Heirloom, a carbon capture company that has raised through Series B). Several portfolio companies operate in Brazil (Mevo, Oya Care, Shopper), reflecting some Latin America exposure alongside a primarily US-focused book. No confirmed exits or IPOs were identified in available sources.
Team
- Edward (Eddie) Segel, General Partner -- Co-founder of Floating Point; founding team member at Oscar Health.
- John Loser, General Partner -- Co-founder of Floating Point; founding team member at Oscar Health.
- Evan Moore, Venture Partner -- Co-founder of DoorDash; former VP Product at Opendoor.
- Serkan Piantino, Venture Partner -- Co-founder of Facebook AI; former VP Product at Reddit.
- Neha Kumar, Venture Partner -- Payer Strategy background at Datavant.
- Jesse Horowitz, Venture Partner -- Former Chief Product Officer at Oscar Health.
- Vinod Mitta, MD, Venture Partner -- Former Medical Officer at CMMI, Centers for Medicare & Medicaid Services.
- Jason Pritzker, Advisor -- The Pritzker Organization; co-founder of 53 Stations.
- Sage Doble, Executive Assistant -- Drives fund and people operations across the firm.
Decision Process
Not explicitly disclosed. With two General Partners plus a bench of operator Venture Partners who bring domain expertise (healthcare, logistics, fintech), the structure suggests a partnership-style process where GPs lead deals with input from relevant Venture Partners, though this is an inference rather than a confirmed process.
Founder Preferences
Floating Point's public materials and portfolio composition suggest a preference for founders tackling structurally complex, capital-intensive, or heavily regulated industries -- the kind of businesses that require deep domain fluency rather than pure software velocity. Both GPs' own founding experience at Oscar Health (a large, operationally complex healthcare insurer) appears to inform a pattern-match toward founders building similarly ambitious, non-obvious businesses.
Geographic Focus
Primarily United States (Boston and New York are the firm's own hubs), with selective exposure to Brazil through several Latin America-focused portfolio companies (Mevo, Oya Care, Shopper).